Elevated IL-6 levels are commonly observed in critical illnesses such as sepsis, acute respiratory distress syndrome (ARDS), and COVID-19, leading to interest in therapeutic strategies aimed at IL-6 inhibition. This evidence concerns the gene IL6 and Sepsis.